首页 > 最新文献

Eksperimental'naia onkologiia最新文献

英文 中文
Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats. 雌激素受体α和β在癌变大鼠乳腺肿瘤中的表达下调。
Pub Date : 2004-03-01
Jin Seok Kang, Na Jin Jung, Seyl Kim, Dae Joong Kim, Dong Deuk Jang, Ki-Hwa Yang

Aim and methods: The recent discovery of a new isoform of estrogen receptor (ER), ER beta, has promoted the investigation of its expression on mammary gland. This study was carried out to examine the expression of ER alpha, ER beta and proliferating cell nuclear antigen (PCNA) in the carcinogen-induced mammary tumors induced by N-methyl-N-nitrosourea (MNU) or 7,12-dimethylbenz[a]anthracene (DMBA), and to compare these expression with those of age-matched normal mammary glands.

Results: There was significant decrease of expression of ER alpha and ER beta in the mammary gland tumors compared with age-matched normal mammary glands (p < 0.05). In mammary gland tumors, ER alpha expression was mainly located in epithelial cells, showing intranuclear staining pattern. The decrease of ER beta expression was so distant that some tumor cells did not show any expression. There was a complete loss of ER beta expression in 50% (7/14) of MNU-induced mammary gland tumors, and 68.2% (15/22) of DMBA-induced mammary gland tumors. However, there was no difference in PCNA expression between mammary gland tumors and normal mammary glands.

Conclusion: This study represents that the decrease of expression of ER alpha and ER beta is associated with mammary carcinogenesis, and suggests that modulation of ER alpha and ER beta may be the target for the treatment of mammary gland tumors.

目的与方法:近年来发现了一种新的雌激素受体(ER)异构体ER β,促进了其在乳腺中的表达研究。本研究旨在检测n-甲基-n -亚硝基脲(MNU)和7,12-二甲基苯[a]蒽(DMBA)诱导的致癌物质诱导的乳腺肿瘤中ER α、ER β和增殖细胞核抗原(PCNA)的表达,并与年龄匹配的正常乳腺进行比较。结果:与年龄匹配的正常乳腺相比,乳腺肿瘤组织中ER α和ER β的表达明显降低(p < 0.05)。在乳腺肿瘤中,ER α主要表达于上皮细胞,呈核内染色模式。ER - β表达的减少是如此遥远,以至于一些肿瘤细胞没有表现出任何表达。50%(7/14)的mnu诱导的乳腺肿瘤和68.2%(15/22)的dmba诱导的乳腺肿瘤中ER β表达完全丧失。乳腺肿瘤组织与正常乳腺组织PCNA的表达无明显差异。结论:本研究提示ER α和ER β表达的降低与乳腺癌的发生有关,提示调节ER α和ER β可能是治疗乳腺肿瘤的靶点。
{"title":"Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats.","authors":"Jin Seok Kang,&nbsp;Na Jin Jung,&nbsp;Seyl Kim,&nbsp;Dae Joong Kim,&nbsp;Dong Deuk Jang,&nbsp;Ki-Hwa Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim and methods: </strong>The recent discovery of a new isoform of estrogen receptor (ER), ER beta, has promoted the investigation of its expression on mammary gland. This study was carried out to examine the expression of ER alpha, ER beta and proliferating cell nuclear antigen (PCNA) in the carcinogen-induced mammary tumors induced by N-methyl-N-nitrosourea (MNU) or 7,12-dimethylbenz[a]anthracene (DMBA), and to compare these expression with those of age-matched normal mammary glands.</p><p><strong>Results: </strong>There was significant decrease of expression of ER alpha and ER beta in the mammary gland tumors compared with age-matched normal mammary glands (p < 0.05). In mammary gland tumors, ER alpha expression was mainly located in epithelial cells, showing intranuclear staining pattern. The decrease of ER beta expression was so distant that some tumor cells did not show any expression. There was a complete loss of ER beta expression in 50% (7/14) of MNU-induced mammary gland tumors, and 68.2% (15/22) of DMBA-induced mammary gland tumors. However, there was no difference in PCNA expression between mammary gland tumors and normal mammary glands.</p><p><strong>Conclusion: </strong>This study represents that the decrease of expression of ER alpha and ER beta is associated with mammary carcinogenesis, and suggests that modulation of ER alpha and ER beta may be the target for the treatment of mammary gland tumors.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"31-5"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2. 全身热疗联合白介素-2增强大鼠对45型肉瘤的抗肿瘤反应。
Pub Date : 2004-03-01
Michael P Potapnev, Yuri P Istomin, Reiman S Ismail-zade, Edvard A Zhavrid

Aim: To evaluate the summarized effect of hyperthermia and interleukin-2 (IL-2) administration on antitumor defense in tumor-bearing rats.

Methods: Nonbred rats after subcutaneous inoculation of sarcoma 45 cells were treated with whole-body hyperthermia (WBH, +42.5 degrees C, 60 min) and interleukin-2 (IL-2, 10,000 U/kg of body weight). Parameters of tumor growth and survival of animals were monitored till day 33 after tumor cell inoculation.

Results: Combined application of WBH and IL-2 at 5th day after tumor cell transplantation resulted in a delay of tumor growth and improvement of survival parameters in comparison with control group or animals that received separate treatment. Therapeutic efficacy of WBH combined with IL-2 was analogous to a single-dose chemotherapy with cyclophosphamide.

Conclusion: Combined application of WBH and IL-2 is the useful approach for cancer immunotherapy.

目的:探讨热疗联合白介素-2 (IL-2)对荷瘤大鼠抗肿瘤防御的综合作用。方法:皮下接种45号肉瘤细胞后,采用全身热疗(WBH, +42.5℃,60 min)和白细胞介素-2 (IL-2, 10000 U/kg体重)处理。观察肿瘤细胞接种后至第33天动物的肿瘤生长和存活情况。结果:在肿瘤细胞移植后第5天,与对照组或单独治疗的动物相比,白头菌与IL-2联合应用可延缓肿瘤生长,改善生存参数。白介素联合白介素-2的治疗效果与单剂量环磷酰胺化疗相似。结论:白骨精联合白介素-2是肿瘤免疫治疗的有效途径。
{"title":"Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.","authors":"Michael P Potapnev,&nbsp;Yuri P Istomin,&nbsp;Reiman S Ismail-zade,&nbsp;Edvard A Zhavrid","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the summarized effect of hyperthermia and interleukin-2 (IL-2) administration on antitumor defense in tumor-bearing rats.</p><p><strong>Methods: </strong>Nonbred rats after subcutaneous inoculation of sarcoma 45 cells were treated with whole-body hyperthermia (WBH, +42.5 degrees C, 60 min) and interleukin-2 (IL-2, 10,000 U/kg of body weight). Parameters of tumor growth and survival of animals were monitored till day 33 after tumor cell inoculation.</p><p><strong>Results: </strong>Combined application of WBH and IL-2 at 5th day after tumor cell transplantation resulted in a delay of tumor growth and improvement of survival parameters in comparison with control group or animals that received separate treatment. Therapeutic efficacy of WBH combined with IL-2 was analogous to a single-dose chemotherapy with cyclophosphamide.</p><p><strong>Conclusion: </strong>Combined application of WBH and IL-2 is the useful approach for cancer immunotherapy.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"67-70"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of polyomavirus DNA in human brain tumors. 人脑肿瘤中多瘤病毒DNA的检测。
Pub Date : 2004-03-01
Iryna G Vasilyeva, Mikhail I Shamaev, Alexandr Ya Glavatskiy, Natalya G Chopick, Natalya P Olexenko, Olga I Tsyubko, Elena S Galanta, Tatyana A Malisheva

Aim: To investigate surgically resected human brain tumors for the presence of polyomavirus DNA.

Materials and methods: 65 samples of surgically resected human brain tumors (57 tumors were of neuroectodermal genesis, 4--mesenchimal, 4--metastatic tumors) were examined for the presence of viral DNA by PCR analysis.

Results: DNA of polyomaviruses was found in oligodendroligomas (66.7% of cases), oligodendroastrocytomas (66.7% of cases) and glioblastomas (40% of cases). In metastatic tumors viral infection had not been detected. No correlation between the grade of brain tumors and infection with polyomavirus DNA has been revealed.

Conclusion: Our data point to importance of investigation of the brain tumors and cerebrospinal fluid for determination of viral infection.

目的:探讨手术切除的人脑肿瘤中多瘤病毒DNA的存在。材料和方法:用PCR方法检测65例手术切除的人脑肿瘤(57例为神经外胚层肿瘤,4例为间质肿瘤,4例为转移性肿瘤)是否存在病毒DNA。结果:在少突胶质细胞瘤(66.7%)、少突胶质细胞瘤(66.7%)和胶质母细胞瘤(40%)中均发现多瘤病毒DNA。在转移性肿瘤中未发现病毒感染。脑肿瘤的分级与多瘤病毒DNA感染之间没有相关性。结论:我们的数据表明脑肿瘤和脑脊液检查对确定病毒感染的重要性。
{"title":"Detection of polyomavirus DNA in human brain tumors.","authors":"Iryna G Vasilyeva,&nbsp;Mikhail I Shamaev,&nbsp;Alexandr Ya Glavatskiy,&nbsp;Natalya G Chopick,&nbsp;Natalya P Olexenko,&nbsp;Olga I Tsyubko,&nbsp;Elena S Galanta,&nbsp;Tatyana A Malisheva","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To investigate surgically resected human brain tumors for the presence of polyomavirus DNA.</p><p><strong>Materials and methods: </strong>65 samples of surgically resected human brain tumors (57 tumors were of neuroectodermal genesis, 4--mesenchimal, 4--metastatic tumors) were examined for the presence of viral DNA by PCR analysis.</p><p><strong>Results: </strong>DNA of polyomaviruses was found in oligodendroligomas (66.7% of cases), oligodendroastrocytomas (66.7% of cases) and glioblastomas (40% of cases). In metastatic tumors viral infection had not been detected. No correlation between the grade of brain tumors and infection with polyomavirus DNA has been revealed.</p><p><strong>Conclusion: </strong>Our data point to importance of investigation of the brain tumors and cerebrospinal fluid for determination of viral infection.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"78-80"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of a new type HPV16 E7 variant isolated from cervical cancer highest incidence area in Hubei Province of China. 湖北省宫颈癌高发区hpv16e7新型变异株的鉴定
Pub Date : 2004-03-01
Hui Li, Min Zhao, Xiaoping Qiu, Xiaohua Ding, Yun Tan, Xinxing Wu

Aim: To investigate the variation and biological properties of HPV16 E7 isolated from cervical cancer biopsy samples from highest incidence area in HuBei province of China.

Methods: HVP16 E7 sequences isolated from the cervical cancer biopsies of 10 local patients were amplified, sequenced and compared with prototype E7 gene. Then the variant gene was cloned into different vectors to study the antigenicity, expression and immunogenicity of its protein by Western blot, immunofluorescence and genetic immunization in vitro or in vivo.

Results: The results showed that 7 of 10 samples had the same mutations which led to a nonsense mutation at codon 43 of E7 sequence. The truncated E7 protein could be recognized by standard E7 monoclonal antibody in Western blot and expressed in NIH3T3 cells. In the blood sera of mice immunized intramuscularly by the plasmid DNA expressing the variant E7 gene specific E7 antibodies could be detected at week 2, 3, 5 and 6 after inoculation. However, no specific lymphoproliferation after E7 protein stimulation in vitro was detected by MTT colorimetric assay in comparison to the prototype E7 protein.

Conclusion: HPV16 E7 gene may show variation in China and the variant protein could be expressed and induce host humoral immune response, but could not elicit special cellular-immune response against it. These data might hold the key for future development of HPV16 vaccine in HuBei province of China.

目的:探讨湖北省高发地区宫颈癌活检标本中分离的hpv16e7的变异及其生物学特性。方法:对10例本地宫颈癌活检患者的HVP16 E7基因进行扩增、测序,并与E7原型基因进行比较。将该变异基因克隆到不同载体中,采用Western blot、免疫荧光和遗传免疫等方法研究其蛋白的抗原性、表达和免疫原性。结果:10份样本中有7份具有相同的突变,导致E7序列密码子43处无义突变。截断的E7蛋白可被标准E7单克隆抗体Western blot识别,并在NIH3T3细胞中表达。用表达E7变异基因的质粒DNA肌内免疫小鼠,在接种后第2、3、5、6周可在小鼠血清中检测到E7特异性抗体。然而,与原型E7蛋白相比,MTT比色法未检测到E7蛋白体外刺激后的特异性淋巴细胞增殖。结论:hpv16e7基因在中国可能存在变异,变异蛋白可以表达并诱导宿主体液免疫应答,但不能引起特异性的细胞免疫应答。这些数据可能为今后湖北省HPV16疫苗的研制提供关键信息。
{"title":"Characterization of a new type HPV16 E7 variant isolated from cervical cancer highest incidence area in Hubei Province of China.","authors":"Hui Li,&nbsp;Min Zhao,&nbsp;Xiaoping Qiu,&nbsp;Xiaohua Ding,&nbsp;Yun Tan,&nbsp;Xinxing Wu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To investigate the variation and biological properties of HPV16 E7 isolated from cervical cancer biopsy samples from highest incidence area in HuBei province of China.</p><p><strong>Methods: </strong>HVP16 E7 sequences isolated from the cervical cancer biopsies of 10 local patients were amplified, sequenced and compared with prototype E7 gene. Then the variant gene was cloned into different vectors to study the antigenicity, expression and immunogenicity of its protein by Western blot, immunofluorescence and genetic immunization in vitro or in vivo.</p><p><strong>Results: </strong>The results showed that 7 of 10 samples had the same mutations which led to a nonsense mutation at codon 43 of E7 sequence. The truncated E7 protein could be recognized by standard E7 monoclonal antibody in Western blot and expressed in NIH3T3 cells. In the blood sera of mice immunized intramuscularly by the plasmid DNA expressing the variant E7 gene specific E7 antibodies could be detected at week 2, 3, 5 and 6 after inoculation. However, no specific lymphoproliferation after E7 protein stimulation in vitro was detected by MTT colorimetric assay in comparison to the prototype E7 protein.</p><p><strong>Conclusion: </strong>HPV16 E7 gene may show variation in China and the variant protein could be expressed and induce host humoral immune response, but could not elicit special cellular-immune response against it. These data might hold the key for future development of HPV16 vaccine in HuBei province of China.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"48-54"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of two different high doses of irradiation on antioxidant system in the liver of guinea pigs. 两种不同高剂量辐照对豚鼠肝脏抗氧化系统的影响。
Pub Date : 2004-03-01
Yildiz Guney, Neslihan Bukan, Aysen Dizman, Ayse Hicsonmez, Ayse Bilgihan

Aim: To examine the state of the oxidant-antioxidant system in the liver of guinea pig caused by high doses of ionizing radiation in the early period.

Methods: The research was carried out on guinea pigs irradiated with the doses of 8 Gy (group 2) or 15 Gy (group 3) (single dose/whole body) in comparison with control group (group 1). The levels of thiobarbituric acid reactive substances (TBARS) and glutathione (GSH), the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and the levels of selenium in the liver were measured.

Results: TBARS levels in the irradiated animals were markedly higher than those in controls. In group 3, GSH levels and GSH-Px activity were significantly increased while activity of SOD and CAT were significantly decreased compared to groups 1 and 2. Liver selenium levels were not influenced by irradiation.

Conclusion: The data have shown that gamma-irradiation at the doses of 8 Gy or 15 Gy results in significant increase in free radical formation while antioxidant enzymes were affected only at a dose of 15 Gy.

目的:探讨早期高剂量电离辐射对豚鼠肝脏氧化-抗氧化系统的影响。方法:采用8 Gy(2组)或15 Gy(3组)单剂量/全身照射豚鼠,与对照组(1组)比较,测定肝组织中硫代巴比妥酸活性物质(TBARS)和谷胱甘肽(GSH)水平、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH- px)活性及硒含量。结果:辐照动物TBARS水平明显高于对照组。与1、2组相比,3组GSH水平和GSH- px活性显著升高,SOD和CAT活性显著降低。肝脏硒水平不受辐照影响。结论:数据表明,8 Gy或15 Gy剂量的γ辐照可显著增加自由基的形成,而抗氧化酶仅在15 Gy剂量时受到影响。
{"title":"Effects of two different high doses of irradiation on antioxidant system in the liver of guinea pigs.","authors":"Yildiz Guney,&nbsp;Neslihan Bukan,&nbsp;Aysen Dizman,&nbsp;Ayse Hicsonmez,&nbsp;Ayse Bilgihan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To examine the state of the oxidant-antioxidant system in the liver of guinea pig caused by high doses of ionizing radiation in the early period.</p><p><strong>Methods: </strong>The research was carried out on guinea pigs irradiated with the doses of 8 Gy (group 2) or 15 Gy (group 3) (single dose/whole body) in comparison with control group (group 1). The levels of thiobarbituric acid reactive substances (TBARS) and glutathione (GSH), the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and the levels of selenium in the liver were measured.</p><p><strong>Results: </strong>TBARS levels in the irradiated animals were markedly higher than those in controls. In group 3, GSH levels and GSH-Px activity were significantly increased while activity of SOD and CAT were significantly decreased compared to groups 1 and 2. Liver selenium levels were not influenced by irradiation.</p><p><strong>Conclusion: </strong>The data have shown that gamma-irradiation at the doses of 8 Gy or 15 Gy results in significant increase in free radical formation while antioxidant enzymes were affected only at a dose of 15 Gy.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"71-4"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poly-drug cancer therapy based on ceramide. 基于神经酰胺的多药癌症治疗。
Pub Date : 2004-03-01
Norman S Radin

Thousands of research studies have reported that many kinds of cancer cells and tumors can be killed by treatments that increase the concentration of a simple cellular sphingolipid, ceramide (Cer). While there are many ways to elevate tumor Cer levels, this approach is complicated by the central, complex role of Cer in cell homeostasis: Cer is readily metabolized to form other sphingolipids that increase the tumor's growth rate, metastasis, and resistance to the patient's immune system. This review points out the need to prevent this metabolic conversion while simultaneously stimulating the enzymes that increase the formation of Cer. I describe here many of the enzymes that need stimulation or inhibition, and drugs or metabolites or dietary components that modify each of the enzymes. The review also points to the importance of the allylic alcohol group in Cer and in many cancer drugs, suggesting that the hydroxyl group participates in phosphate transfer to and from proteins by forming a temporary phosphate ester. The allylic hydroxyl may also reduce the ketone moieties in mitochondrial ubiquinone, with formation of reactive oxygen species and apoptogenic breakdown. The level of Cer in tumors can be increased by: (1) direct administration of Cer or a Cer analogue, and (2) stimulation of Cer synthesis from its elementary precursors, or from (3) sphingomyelin by hydrolysis, or from (4) the glucosphingolipids by hydrolysis, or (5) by acylation of sphingosine. In addition, Cer concentration can be raised by slowing its conversion to (6) sphingomyelin, (7) glucosylCer, (8) Cer phosphate, and (9) sphingosine + fatty acid by hydrolysis. Therapeutic radiation stimulates the de novo synthesis of Cer in tumors. Conversion of sphingosine (from Cer) to sphingosine phosphate probably also ought to be blocked.

成千上万的研究报告称,通过增加一种简单的细胞鞘脂神经酰胺(Cer)的浓度,可以杀死许多种类的癌细胞和肿瘤。虽然有许多方法可以提高肿瘤的Cer水平,但由于Cer在细胞稳态中的中心和复杂作用,这种方法变得复杂:Cer很容易代谢形成其他鞘脂,从而增加肿瘤的生长速度、转移和对患者免疫系统的抵抗力。这篇综述指出,需要防止这种代谢转化,同时刺激增加Cer形成的酶。我在这里描述了许多需要刺激或抑制的酶,以及改变每种酶的药物、代谢物或饮食成分。该综述还指出了烯丙醇基团在Cer和许多癌症药物中的重要性,表明羟基通过形成临时磷酸酯参与磷酸盐在蛋白质之间的转移。烯丙基羟基也可能使线粒体泛醌中的酮类基团减少,形成活性氧和凋亡性分解。肿瘤中Cer的水平可以通过以下方式增加:(1)直接给药Cer或Cer类似物,(2)刺激其基本前体合成Cer,或(3)通过水解鞘磷脂,或(4)通过水解葡萄糖脂,或(5)通过鞘磷脂的酰化。此外,通过减缓其水解转化为(6)鞘磷脂、(7)葡萄糖、(8)磷酸Cer和(9)鞘磷脂+脂肪酸,可以提高Cer的浓度。治疗性放射刺激肿瘤中Cer的重新合成。鞘氨醇(从Cer)向鞘氨醇磷酸的转化可能也应该被阻断。
{"title":"Poly-drug cancer therapy based on ceramide.","authors":"Norman S Radin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Thousands of research studies have reported that many kinds of cancer cells and tumors can be killed by treatments that increase the concentration of a simple cellular sphingolipid, ceramide (Cer). While there are many ways to elevate tumor Cer levels, this approach is complicated by the central, complex role of Cer in cell homeostasis: Cer is readily metabolized to form other sphingolipids that increase the tumor's growth rate, metastasis, and resistance to the patient's immune system. This review points out the need to prevent this metabolic conversion while simultaneously stimulating the enzymes that increase the formation of Cer. I describe here many of the enzymes that need stimulation or inhibition, and drugs or metabolites or dietary components that modify each of the enzymes. The review also points to the importance of the allylic alcohol group in Cer and in many cancer drugs, suggesting that the hydroxyl group participates in phosphate transfer to and from proteins by forming a temporary phosphate ester. The allylic hydroxyl may also reduce the ketone moieties in mitochondrial ubiquinone, with formation of reactive oxygen species and apoptogenic breakdown. The level of Cer in tumors can be increased by: (1) direct administration of Cer or a Cer analogue, and (2) stimulation of Cer synthesis from its elementary precursors, or from (3) sphingomyelin by hydrolysis, or from (4) the glucosphingolipids by hydrolysis, or (5) by acylation of sphingosine. In addition, Cer concentration can be raised by slowing its conversion to (6) sphingomyelin, (7) glucosylCer, (8) Cer phosphate, and (9) sphingosine + fatty acid by hydrolysis. Therapeutic radiation stimulates the de novo synthesis of Cer in tumors. Conversion of sphingosine (from Cer) to sphingosine phosphate probably also ought to be blocked.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"3-10"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24491583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental immunotherapy of mice with transplanted MC-rhabdomyosarcoma resistant to doxorubicin. 多柔比星耐药小鼠移植mc -横纹肌肉瘤的实验性免疫治疗。
Pub Date : 2004-03-01
Ninel M Berezhnaya, Elena V Kovalchuk, Yulya D Vinnichuk, Svetlana I Spivak, Oxana B Belova

Aim: To compare the sensitivity of doxorubicin (DOX) sensitive and DOX-resistant MC-rhabdomyosarcoma (MC-RMS) cells to the action of lymphokine-activated cells (LAC).

Results: In vitro investigations showed that LAC received from the fraction of adherent lymphocytes possess the highest activity against DOX-resistant tumor cells, and LAC from lymphocytes of total pool--against DOX-resistant tumor cells pretreated with DOX at a low dose. Adoptive immunotherapy of MC-RMS in vivo showed the highest efficacy in the cases of LAC intratumoral injection and the one combined with intraperitoneal administration of DOX at a low dose (increase of survival time by 14% and 25%, respectively).

Conclusion: Adoptive in vivo therapy of DOX-resistant Mh-RMS is effective if LAC or their combination with DOX at a low dose are administered.

目的:比较多柔比星(DOX)敏感和耐药MC-rhabdomyosarcoma (MC-RMS)细胞对淋巴因子活化细胞(LAC)的敏感性。结果:体外研究表明,贴壁淋巴细胞部分获得的LAC对DOX耐药肿瘤细胞的活性最高,而总池淋巴细胞获得的LAC对低剂量DOX预处理的DOX耐药肿瘤细胞的活性最高。体内MC-RMS过继免疫治疗在肿瘤内注射LAC和低剂量腹腔注射DOX的情况下疗效最高(生存时间分别增加14%和25%)。结论:低剂量给药LAC或与DOX联用,对DOX耐药的Mh-RMS是有效的。
{"title":"Experimental immunotherapy of mice with transplanted MC-rhabdomyosarcoma resistant to doxorubicin.","authors":"Ninel M Berezhnaya,&nbsp;Elena V Kovalchuk,&nbsp;Yulya D Vinnichuk,&nbsp;Svetlana I Spivak,&nbsp;Oxana B Belova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To compare the sensitivity of doxorubicin (DOX) sensitive and DOX-resistant MC-rhabdomyosarcoma (MC-RMS) cells to the action of lymphokine-activated cells (LAC).</p><p><strong>Results: </strong>In vitro investigations showed that LAC received from the fraction of adherent lymphocytes possess the highest activity against DOX-resistant tumor cells, and LAC from lymphocytes of total pool--against DOX-resistant tumor cells pretreated with DOX at a low dose. Adoptive immunotherapy of MC-RMS in vivo showed the highest efficacy in the cases of LAC intratumoral injection and the one combined with intraperitoneal administration of DOX at a low dose (increase of survival time by 14% and 25%, respectively).</p><p><strong>Conclusion: </strong>Adoptive in vivo therapy of DOX-resistant Mh-RMS is effective if LAC or their combination with DOX at a low dose are administered.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"63-6"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative metabolism of rat blood in the course of alveolar hepatic carcinoma PC-1 growth. 肺泡型肝癌PC-1生长过程中大鼠血液氧化代谢的变化。
Pub Date : 2004-03-01
R M Smolyakova, V I Prokhorova, E A Zhavrid, A A Mashevsky, Yu P Istomin

Aim: To evaluate oxidative metabolism of rat blood in the course of alveolar hepatic cancer growth in vivo.

Methods: The oxidation imbalance was assessed by the rise in the values of the integral index of oxidation stress. The structural and functional state of erythrocyte membranes was investigated by spin electron paramagnetic resonance spectroscopy.

Results: The growth of alveolar carcinoma was found to be associated with intensification of lipid peroxidation processes with increased blood content of conjugated dienes, malonic dialdehyde against the background of decreased concentration of endogenous antioxidants tocopherol and retinol. Destabilization of the structural state of erythrocyte membranes of rat tumor hosts at the development of oxidation stress was studied, which was characterized by nonspecific structural changes of membrane sorption centres, reduction in specific capacity in the protein-lipid contact area and its increase in the phospholipid bilayer, rise in the degree of order and polarity.

Conclusion: Alveolar carcinoma growth in rats resulted in intensification of free radical lipid peroxidation processes with a shift of the prooxidant-antioxidant balance to the left and development of oxidation stress.

目的:探讨大鼠肺泡肝癌生长过程中血液氧化代谢的变化。方法:通过氧化应激积分指数的升高来评价氧化失衡。用自旋电子顺磁共振波谱法研究了红细胞膜的结构和功能状态。结果:肺泡癌的生长与脂质过氧化过程的加剧有关,与内源性抗氧化剂生育酚和视黄醇浓度降低的背景下,血液中共轭二烯、丙二醛含量增加有关。研究了氧化应激发生时大鼠肿瘤宿主红细胞膜结构状态的不稳定,其特征是膜吸收中心的非特异性结构改变,蛋白脂接触区比容量降低,磷脂双分子层比容量增加,有序度和极性升高。结论:大鼠肺泡癌生长导致自由基脂质过氧化过程增强,促氧化-抗氧化平衡左移,氧化应激发生。
{"title":"Oxidative metabolism of rat blood in the course of alveolar hepatic carcinoma PC-1 growth.","authors":"R M Smolyakova,&nbsp;V I Prokhorova,&nbsp;E A Zhavrid,&nbsp;A A Mashevsky,&nbsp;Yu P Istomin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate oxidative metabolism of rat blood in the course of alveolar hepatic cancer growth in vivo.</p><p><strong>Methods: </strong>The oxidation imbalance was assessed by the rise in the values of the integral index of oxidation stress. The structural and functional state of erythrocyte membranes was investigated by spin electron paramagnetic resonance spectroscopy.</p><p><strong>Results: </strong>The growth of alveolar carcinoma was found to be associated with intensification of lipid peroxidation processes with increased blood content of conjugated dienes, malonic dialdehyde against the background of decreased concentration of endogenous antioxidants tocopherol and retinol. Destabilization of the structural state of erythrocyte membranes of rat tumor hosts at the development of oxidation stress was studied, which was characterized by nonspecific structural changes of membrane sorption centres, reduction in specific capacity in the protein-lipid contact area and its increase in the phospholipid bilayer, rise in the degree of order and polarity.</p><p><strong>Conclusion: </strong>Alveolar carcinoma growth in rats resulted in intensification of free radical lipid peroxidation processes with a shift of the prooxidant-antioxidant balance to the left and development of oxidation stress.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"36-9"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue. 核因子κ B调节人结直肠癌组织中环氧合酶-2的表达和细胞增殖。
Pub Date : 2004-03-01
Liang-Liang Yu, Hong-Gang Yu, Jie-Ping Yu, He-Sheng Luo

Objective: Activation of transcription factor nuclear factor-kappa B (NF-kappa B) has been shown to play a role in cell proliferation, apoptosis, cytokine production, and oncogenesis. The purpose of this study was to determine whether NF-kappa B is constitutively activated in human colorectal tumor tissues and, if so, to determine the role of NF-kappa B in colorectal tumorigenesis, furthermore, to determine the association of RelA expression with the expression of cyclooxygenase-2 (COX-2) and tumor cell proliferation.

Methods: Paraffin sections of the normal epithelial, adenomatous and adenocarcinoma tissue were analysed immunohistochemically for RelA, COX-2, Ki-67 protein expression. EMSA (electrophoretic mobility shift assay) was used to confirm the increased nuclear translocation of RelA in colorectal tumor tissues. The expression of COX-2 mRNA was determined by RT-PCR (reverse transcription polymerase chain reaction) analysis.

Results: Activation of NF-kappa B was significantly higher in adenocarcinoma tissue in comparison to that in adenomatous and normal epithelial tissue. The colon tumor cell proliferation, mRNA expression and protein level of COX-2 were significantly increased in the transition from normal to tumor tissue.

Conclusion: Our results suggest that NF-kappa B may promote proliferation via enhancing the expression of COX-2, and the increased expression of RelA/nuclear factor-kappa B plays an important role in the pathogenesis of colorectal carcinoma.

目的:转录因子核因子- κ B (nf - κ B)的激活已被证明在细胞增殖、凋亡、细胞因子产生和肿瘤发生中发挥作用。本研究的目的是确定NF-kappa B是否在人类结直肠肿瘤组织中被组成性激活,如果是,则确定NF-kappa B在结直肠肿瘤发生中的作用,进而确定RelA表达与环氧化酶-2 (COX-2)表达和肿瘤细胞增殖的关系。方法:对正常上皮组织、腺瘤组织和腺癌组织石蜡切片进行免疫组化分析,检测RelA、COX-2、Ki-67蛋白的表达。EMSA(电泳迁移迁移试验)证实RelA在结直肠肿瘤组织中的核易位增加。逆转录聚合酶链反应(RT-PCR)检测COX-2 mRNA的表达。结果:腺癌组织中NF-kappa B的活性明显高于腺瘤组织和正常上皮组织。在正常组织向肿瘤组织转变过程中,结肠肿瘤细胞增殖、COX-2 mRNA表达及蛋白水平均显著升高。结论:NF-kappa B可能通过增强COX-2的表达促进细胞增殖,而RelA/nuclear factor-kappa B的表达升高在结直肠癌的发病过程中起重要作用。
{"title":"Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.","authors":"Liang-Liang Yu,&nbsp;Hong-Gang Yu,&nbsp;Jie-Ping Yu,&nbsp;He-Sheng Luo","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Activation of transcription factor nuclear factor-kappa B (NF-kappa B) has been shown to play a role in cell proliferation, apoptosis, cytokine production, and oncogenesis. The purpose of this study was to determine whether NF-kappa B is constitutively activated in human colorectal tumor tissues and, if so, to determine the role of NF-kappa B in colorectal tumorigenesis, furthermore, to determine the association of RelA expression with the expression of cyclooxygenase-2 (COX-2) and tumor cell proliferation.</p><p><strong>Methods: </strong>Paraffin sections of the normal epithelial, adenomatous and adenocarcinoma tissue were analysed immunohistochemically for RelA, COX-2, Ki-67 protein expression. EMSA (electrophoretic mobility shift assay) was used to confirm the increased nuclear translocation of RelA in colorectal tumor tissues. The expression of COX-2 mRNA was determined by RT-PCR (reverse transcription polymerase chain reaction) analysis.</p><p><strong>Results: </strong>Activation of NF-kappa B was significantly higher in adenocarcinoma tissue in comparison to that in adenomatous and normal epithelial tissue. The colon tumor cell proliferation, mRNA expression and protein level of COX-2 were significantly increased in the transition from normal to tumor tissue.</p><p><strong>Conclusion: </strong>Our results suggest that NF-kappa B may promote proliferation via enhancing the expression of COX-2, and the increased expression of RelA/nuclear factor-kappa B plays an important role in the pathogenesis of colorectal carcinoma.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"40-7"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy. 细胞因子激活的T淋巴细胞的抗肿瘤免疫作用不同,这些T淋巴细胞来自幼年小鼠脾细胞和基于树突状细胞疫苗的脾细胞:过继免疫治疗的意义
Pub Date : 2004-03-01
Sheng Zhang, Qin Wang, Wen-Feng Li, Hong-Yi Wang, Hong-Jun Zhang, Jing-Juan Zhu

Aim: The aim of the study is to explore the antitumor capacity of effector cells generated from murine splenocytes with sequential addition of a cocktail of cytokines and the possible contribution of dendritic cells to the antitumor capacity of these effector cells.

Methods and results: Interferon-gamma, interleukin (IL)-1 beta, anti-CD3 mAb and IL-2 were used to activate murine splenocytes either from naive mice (termed cytokine activated T cells, CAT) or from DC based vaccine primed mice (termed specific effector T cells, SET). The antitumor roles of SET and CAT were analyzed in murine L615 T lymphocytic leukemia. Both CAT and SET were CD4(+)-predominant phenotypically and didn't show any significant cytotoxicity against a variety of syngeneic and allogeneic target cell lines using 51Cr release assay. When injected in vivo in combination with CY, CAT can cure a large proportion of leukemia mice. The cured mice couldn't establish specific antitumor immunity. However, in contrast to the roles of CAT, SET show far superior antitumor efficacy on a per cell basis compared with CAT. Moreover, the SET cured mice developed tumor specific long term memory immunity which was sufficient to reject a subsequent otherwise lethal tumor cells rechallenge and was transferable to naive immunocompetent mice.

Conclusion: Our data demonstrate that there remain fundamentally different antitumor functions of CAT and SET which might be useful in the immunotherapy strategy choices.

目的:本研究的目的是探讨小鼠脾细胞在连续添加细胞因子鸡尾酒后产生的效应细胞的抗肿瘤能力,以及树突状细胞对这些效应细胞抗肿瘤能力的可能贡献。方法和结果:使用干扰素- γ、白细胞介素(IL)-1 β、抗cd3单抗和IL-2来激活小鼠脾细胞,无论是来自幼稚小鼠(称为细胞因子活化T细胞,CAT)还是来自基于DC的疫苗引物小鼠(称为特异性效应T细胞,SET)。分析了SET和CAT在小鼠L615 T淋巴细胞白血病中的抗肿瘤作用。在51Cr释放试验中,CAT和SET均表现为CD4(+)显性,对多种同基因和异体靶细胞系没有明显的细胞毒性。当与CY联合体内注射时,CAT可以治愈大部分白血病小鼠。治愈小鼠不能建立特异性抗肿瘤免疫。然而,与CAT的作用相比,SET在每个细胞的基础上显示出远优于CAT的抗肿瘤功效。此外,SET治愈的小鼠产生了肿瘤特异性长期记忆免疫,足以拒绝随后致命的肿瘤细胞的再攻击,并可转移到初始免疫能力小鼠身上。结论:我们的数据表明,CAT和SET的抗肿瘤功能仍然存在根本差异,这可能有助于免疫治疗策略的选择。
{"title":"Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy.","authors":"Sheng Zhang,&nbsp;Qin Wang,&nbsp;Wen-Feng Li,&nbsp;Hong-Yi Wang,&nbsp;Hong-Jun Zhang,&nbsp;Jing-Juan Zhu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>The aim of the study is to explore the antitumor capacity of effector cells generated from murine splenocytes with sequential addition of a cocktail of cytokines and the possible contribution of dendritic cells to the antitumor capacity of these effector cells.</p><p><strong>Methods and results: </strong>Interferon-gamma, interleukin (IL)-1 beta, anti-CD3 mAb and IL-2 were used to activate murine splenocytes either from naive mice (termed cytokine activated T cells, CAT) or from DC based vaccine primed mice (termed specific effector T cells, SET). The antitumor roles of SET and CAT were analyzed in murine L615 T lymphocytic leukemia. Both CAT and SET were CD4(+)-predominant phenotypically and didn't show any significant cytotoxicity against a variety of syngeneic and allogeneic target cell lines using 51Cr release assay. When injected in vivo in combination with CY, CAT can cure a large proportion of leukemia mice. The cured mice couldn't establish specific antitumor immunity. However, in contrast to the roles of CAT, SET show far superior antitumor efficacy on a per cell basis compared with CAT. Moreover, the SET cured mice developed tumor specific long term memory immunity which was sufficient to reject a subsequent otherwise lethal tumor cells rechallenge and was transferable to naive immunocompetent mice.</p><p><strong>Conclusion: </strong>Our data demonstrate that there remain fundamentally different antitumor functions of CAT and SET which might be useful in the immunotherapy strategy choices.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"26 1","pages":"55-62"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24492567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eksperimental'naia onkologiia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1